Latest Breaking News On - Bogan sleep consultants - Page 1 : comparemela.com

Part 4: LXB as Effective as SXB for Cataplexy, EDS, With Less Sodium

Lower-sodium oxybate (LXB) and sodium oxybate (SXB) were proven equally effective for cataplexy and excessive daytime sleepiness (EDS), despite LXB having 92% less sodium.

United statesRichardk boganAmerican academy of sleep medicineUniversity of south carolina school medicineBogan sleep consultantsAmerican college of chest physiciansAmerican collegeChest physiciansAmerican academySleep medicineSouth carolina schoolAmerican journalBogan sleepSodium oxybateLower sodium oxybateExcessive daytime sleepiness

Addressing the Burden of Cardiovascular Comorbidities in Narcolepsy: Strategies and Perspectives to Optimize Treatment and Patient Outcomes

Addressing the Burden of Cardiovascular Comorbidities in Narcolepsy: Strategies and Perspectives to Optimize Treatment and Patient Outcomes
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

United statesMichaelj thorpyVirendk somersRichardk boganJazz pharmaceuticals incMontefiore medical centerWake disorders centerProgram overviewAccreditation council for continuing medical educationCardiometabolic health congressAmerican nurses credentialing centerBogan sleep consultantsAccreditation council for pharmacy educationHealthy hummingDepartment of neurologySpeakers bureau for jazz

Burden of Idiopathic Hypersomnia

People with idiopathic hypersomnia face a significant disease burden, including challenges that impact daily living activities.

South carolinaUnited statesSree royRichardk boganRichard boganJazz pharmaceuticalsHypersomnia foundationSleep reviewBogan sleep consultantsIdiopathic hypersomnia severity scale

FDA grants de novo status to restless legs syndrome therapy

The FDA has granted Noctrix Health its de novo request for the NTX100 Tonic Motor Activation System, the first therapy for patients with moderate to severe, drug-refractory restless legs syndrome, according to a company press release.

Heather bieleShri raghunathanRichard boganUniversity of south carolina school medicineNoctrix healthMotor activation systemMotor activationSouth carolina schoolBogan sleep consultants

Noctrix Health announces successful randomized controlled trial (RCT) outcomes and FDA Marketing Authorization for its Breakthrough Tonic Motor Activation (TOMAC) Restless Legs Syndrome (RLS) Therapy

/PRNewswire/ Noctrix Health announced that the U.S. Food and Drug Administration (FDA) has granted its De Novo request for the NTX100 Tonic Motor Activation.

United statesMark buchfuhrerRichard boganShri raghunathanAsim royOhio sleep medicine instituteNoctrix health incDrug administrationNoctrix healthBogan sleep consultantsPrnewswire noctrix healthMotor activationPrincipal investigatorClinical associate professorSouth carolina schoolPrincipal investigators